
Aprea Therapeutics Investor Relations Material
Latest events

Study Update
Aprea Therapeutics

Q1 2025
14 May, 2025

Q4 2024
25 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aprea Therapeutics Inc
Access all reports
Aprea Therapeutics Inc. is a biopharmaceutical company focused on developing cancer treatments. The company specializes in small-molecule therapies that target tumor suppressor pathways to address various malignancies. Its research and development efforts aim to enhance the effectiveness of existing treatments and explore novel therapeutic approaches. The company is headquartered in Doylestown, Pennsylvania, and its shares are listed on the NASDAQ.
Key slides for Aprea Therapeutics Inc


Corporate Presentation
Aprea Therapeutics Inc


Corporate Presentation
Aprea Therapeutics Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
APRE
Country
🇺🇸 United States